Access Bio, Inc. (KOSDAQ:A950130) announces a share repurchase program. Under the program, the company will repurchase up to KRW 30,000 million worth of shares pursuant to a contract with Korea Investment & Securities Co., Ltd. The purpose of the share repurchase is to enhance shareholder value and stabilize stock price. The repurchase program will expire on March 23, 2023.

As of March 23, 2022, the company had 713,515 shares within scope available for dividend and had no shares in treasury through other repurchase.